Calyxt (CLXT) Explores Strategic Alternatives

Go back to Calyxt (CLXT) Explores Strategic Alternatives

Calyxt, Inc. Exploring Strategic Alternatives

September 22, 2022 7:00 AM UTC

ROSEVILLE, Minn., Sept. 22, 2022 /PRNewswire/ -- Calyxt, Inc. (NASDAQ: CLXT) ("Calyxt"), a plant-based synthetic biology company, today announced that its Board of Directors is evaluating potential strategic alternatives to maximize shareholder value. As part of the process, the Board is considering a full range of strategic alternatives, which may include financing alternatives, merger, reverse merger, other business combinations, sale of assets, licensing, or other transactions. Calyxt has retained Canaccord Genuity as its financial advisor and Sidley Austin as its legal counsel to... More